Skip to content

Drug interactions

Crizotinib + Nilotinib

Severity: Major

Crizotinib and Nilotinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs prolong the QT interval, and crizotinib also causes bradycardia. Combined use may increase the risk of torsades de pointes. Crizotinib is a CYP3A4 inhibitor and nilotinib is a CYP3A4 substrate, which may further raise nilotinib exposure.

What this interaction means in plain words

Crizotinib and Nilotinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Crizotinib belongs to Oncology; Nilotinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive QT prolongation plus CYP3A4 inhibition by crizotinib increasing nilotinib levels.

What to do

Avoid if possible; if combined, monitor ECG and electrolytes and heart rate frequently, and reduce or interrupt therapy if QTc becomes markedly prolonged.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Crizotinib and Nilotinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Crizotinib with Nilotinib?

MediHelp rates the interaction as major. Crizotinib and Nilotinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both drugs prolong the QT interval, and crizotinib also causes bradycardia. Combined use may increase the risk of torsades de pointes. Crizotinib is a CYP3A4 inhibitor and nilotinib is a CYP3A4 substrate, which may further raise nilotinib exposure.

How serious is the interaction between Crizotinib and Nilotinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if possible; if combined, monitor ECG and electrolytes and heart rate frequently, and reduce or interrupt therapy if QTc becomes markedly prolonged.

What other medicines interact with Nilotinib?

MediHelp also lists interactions of Nilotinib with, for example, Amiodarone, Arsenic trioxide, Disopyramide. The full list is on the Nilotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in